EN
instrument_fundamentals
| date | Close | change | Change (%) | instr__open | High | Low |
|---|
News
Merck & Co., Inc. (NYSE:MRK) Stock Price Down 0.8% - Time to Sell?
BMO Capital Markets Downgrades Merck & Co., Inc. (NYSE:MRK) to Market Perform
Is Merck & Co. (MRK) a Cheap NYSE Stock to Invest in Now?
Merck & Co., Inc. (NYSE:MRK) Trading 0.5% Higher - Still a Buy?
Merck Reports Topline Data From Phase 3 Trials Of Doravirine + Islatravir To Treat HIV-1 Infection
Why Is Merck & Co., Inc. (MRK) Among the Best Dividend Stocks to Invest In?
Merck Enters Obesity Space, Buys Rights to Hansoh's Oral GLP-1 Drug - December 19, 2024 - Zacks.com
Merck & Co., Inc. (NYSE:MRK) Trading Up 0.4% - Still a Buy?
Merck strikes a $2B GLP-1 deal with Hansoh | BioWorld
Strong Fundamentals And Weight Loss Entry Make Merck (MRK) A Buy
Merck, Hansoh Pharma in Obesity Pill License Potentially Worth More Than $2 Billion | Morningstar
Merck stock rises following Hansoh Pharma deal By Investing.com
Syntax Research Inc. Buys 10,000 Shares of Merck & Co., Inc. (NYSE:MRK)
Merck Enters Into Exclusive Global License Agreement With Hansoh Pharma For HS-10535
Here is the full article based on the provided information: By Investing.com
Virtu Financial LLC Reduces Stake in Merck & Co., Inc. (NYSE:MRK)
Merck & Company’s Strategic Pivots and Growth Potential: A Buy Rating Justification
Merck & Co. signs license agreement for Hansoh Pharma GLP-1 receptor agonist | BioWorld
Merck & Co., Inc. (NYSE:MRK) Trading Down 0.1% - Here's What Happened
Gordon Reid's Past Pick: Elevance Health, Merck & Co. and RTX – BNN Bloomberg
Merck Gets FDA Review of Clesrovimab RSV Vaccine Candidate | Morningstar
Is Merck & Co., Inc. (MRK) the Best Weight Loss Stock to Buy Now According to Hedge Funds?
Vaccinex to be delisted from Nasdaq over equity shortfall By Investing.com
Merck Ends Development of Two Experimental Cancer Drugs - December 17, 2024 - Zacks.com
Merck & Co Inc (MRK) Discontinues Development of Vibostolimab and Favezelimab
Merck & Co., Inc. (NYSE:MRK) Trading 0.5% Higher – Time to Buy?
Merck & Co., Inc. (NYSE:MRK) Trading 0.5% Higher - Time to Buy?
Merck Provides Update on KeyVibe and KEYFORM Clinical Development Programs Evaluating Investigational Vibostolimab and Favezelimab Fixed-Dose Combinations with Pembrolizumab By Investing.com
Bernstein Keeps Their Hold Rating on Merck & Company (MRK) | Markets Insider
China Approves Merck's Keytruda To Treat Patients With Resectable Stage II, IIIA Or IIIB NSCLC
CHMP Endorses Merck's Kidney Cancer Drug for Two Indications - December 16, 2024 - Zacks.com
Lord Abbett & CO. LLC Has $44.33 Million Stake in Merck & Co., Inc. (NYSE:MRK)
Merck & Co., Inc. (NYSE:MRK) Plans Quarterly Dividend of $0.81
B. Riley Wealth Advisors Inc. Has $14.41 Million Stake in Merck & Co., Inc. (NYSE:MRK)
Merck & Co., Inc. (NYSE:MRK) Shares Up 0.3% - Still a Buy?
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Asset Advisors Investment Management LLC
1ST Source Bank Has $11.56 Million Stock Holdings in Merck & Co., Inc. (NYSE:MRK)
Merck & Co., Inc. (NYSE:MRK) Holdings Raised by Birmingham Capital Management Co. Inc. AL
DGS Capital Management LLC Acquires 718 Shares of Merck & Co., Inc. (NYSE:MRK)
Merck & Co., Inc. (NYSE:MRK) Position Reduced by Retirement Systems of Alabama
Oddo BHF Asset Management Sas Makes New Investment in Merck & Co., Inc. (NYSE:MRK)
Merck & Co., Inc. (NYSE:MRK) Shares Purchased by Franklin Resources Inc.
Synovus Financial Corp Raises Stock Holdings in Merck & Co., Inc. (NYSE:MRK)
Merck: WELIREG Gets Positive EU CHMP Opinion For VHL Tumors, Advanced RCC | Markets Insider
Merck & Co. Gets Key European Backing for Welireg in Two Uses | Morningstar
SkyView Investment Advisors LLC Trims Stock Position in Merck & Co., Inc. (NYSE:MRK)
Merck & Co., Inc. (NYSE:MRK) is Te Ahumairangi Investment Management Ltd’s 10th Largest Position
Merck & Co., Inc. (NYSE:MRK) Shares Bought by Boyar Asset Management Inc.
Sculati Wealth Management LLC Acquires 419 Shares of Merck & Co., Inc. (NYSE:MRK)
Merck & Co., Inc. (NYSE:MRK) Stock Price Up 1.5% - What's Next?
Tidal Investments LLC Acquires 55,048 Shares of Merck & Co., Inc. (NYSE:MRK)
Merck & Co., Inc. (NYSE:MRK) Shares Acquired by Wilmington Savings Fund Society FSB
26,072 Shares in Merck & Co., Inc. (NYSE:MRK) Bought by Arvest Bank Trust Division
World Investment Advisors LLC Increases Stake in Merck & Co., Inc. (NYSE:MRK)
Sanctuary Advisors LLC Has $53.80 Million Position in Merck & Co., Inc. (NYSE:MRK)
Merck & Co., Inc. (NYSE:MRK) Shares Down 2.2% – Should You Sell?
12,913 Shares in Merck & Co., Inc. (NYSE:MRK) Bought by Eaton Financial Holdings Company LLC
Cancer Vaccines Market worth $20.47 billion in 2032
Morse Asset Management Inc Sells 14,932 Shares of Merck & Co., Inc. (NYSE:MRK)
Rep. Jared Moskowitz Buys Merck & Co., Inc. (NYSE:MRK) Shares
Merck & Co., Inc. (NYSE:MRK) Shares Down 0.4% - Time to Sell?
Merck & Co., Inc. (NYSE:MRK) Shares Acquired by Rehmann Capital Advisory Group
Unigestion Holding SA Cuts Position in Merck & Co., Inc. (NYSE:MRK)
Merck & Co Inc (MRK) Announces Promising Long-Term Results from OlympiA Phase 3 Trial
LYNPARZA® (olaparib) demonstrated clinically meaningful prolonged survival benefit in early breast cancer in OlympiA Phase III trial | Morningstar
Unigestion Holding SA Sells 330,882 Shares of Merck & Co., Inc. (NYSE:MRK)
TD Private Client Wealth LLC Reduces Stock Holdings in Merck & Co., Inc. (NYSE:MRK)
Toronto Dominion Bank Trims Position in Merck & Co., Inc. (NYSE:MRK)
Neo Ivy Capital Management Makes New Investment in Merck & Co., Inc. (NYSE:MRK)
Immutep reports positive data in head and neck cancer trial
Is Merck & Co., Inc. (MRK) the Best American Dividend Stock to Buy Right Now?
The Zacks Analyst Blog Alphabet, Oracle, Merck & Co, Canterbury Park and CompX International - December 11, 2024 - Zacks.com
Merck & Co., Inc. (NYSE:MRK) Trading Down 2.2% - What's Next?
Vestcor Inc Raises Position in Merck & Co., Inc. (NYSE:MRK)
High Falls Advisors Inc Sells 185 Shares of Merck & Co., Inc. (NYSE:MRK)
Coldstream Capital Management Inc. Acquires 7,544 Shares of Merck & Co., Inc. (NYSE:MRK)
Coldstream Capital Management Inc. Buys 7,544 Shares of Merck & Co., Inc. (NYSE:MRK)
Merck & Co., Inc.'s (MRK) "Buy" Rating Reiterated at Bank of America
Geode Capital Management LLC Acquires 2,134,296 Shares of Merck & Co., Inc. (NYSE:MRK)
Greenwood Gearhart Inc. Acquires 10,551 Shares of Merck & Co., Inc. (NYSE:MRK)
Vestcor Inc Acquires 28,360 Shares of Merck & Co., Inc. (NYSE:MRK)
Resources Management Corp CT ADV Acquires 11,341 Shares of Merck & Co., Inc. (NYSE:MRK)
Executive Wealth Management LLC Buys 37,059 Shares of Merck & Co., Inc. (NYSE:MRK)
IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer | Morningstar
Merck & Co., Inc. (NYSE:MRK) Stock Acquired Rep. Jared Moskowitz
IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® By Investing.com
Merck & Co., Inc. (NYSE:MRK) Shares Up 1.2% - What's Next?
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Geller Advisors LLC
LRI Investments LLC Purchases 8,751 Shares of Merck & Co., Inc. (NYSE:MRK)
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Public Employees Retirement System of Ohio
Why Merck & Co. (MRK) Is the Best Beginner Stock to Invest in Now?
BRIDGING CLINICAL RESEARCH AND CLINICAL CARE WITH AI-AIDING PATHOLOGISTS TOOL | The Manila Times
Kimelman & Baird LLC Sells 660 Shares of Merck & Co., Inc. (NYSE:MRK)
Merck & Co., Inc. (NYSE:MRK) Shares Purchased by MML Investors Services LLC
Hodges Capital Management Inc. Boosts Stake in Merck & Co., Inc. (NYSE:MRK)
20,000 Shares in Merck & Co., Inc. (NYSE:MRK) Bought by Anson Funds Management LP
